Navigation Links
Tomato Extract Found To Reduce The Risk Of Thrombosis

Provexis, UK functional food developer has entered into an initial three-year agreement// with the registered heart health charity, Heart UK to endorse its new juice drink Sirco.

The product, based on a proprietary tomato extract has been shown in trials to reduce the risk of thrombosis, a major cause of heart attack and stroke.

It will carry the Heart UK logo and also carry the claim: ‘Helps to maintain a healthy heart and benefits the circulation.'

The charity will collaborate with Provexis in research and educational activities designed to increase awareness of family heart health issues. The move is expected to fit with the company's strategy to differentiate in the functional food industry by investing in R&D and developing products that taste great, deliver proven health benefits, and carry credible health claims supported by strong scientific proof.

Medindia on Cancer And Super Foods: Their World The most dreaded and rampart diseases today are diabetes and cancer. The interesting thing is that recent researches have proved that both these can be controlled by nutrition and diet. In the same league as social and preventive medicine c is the mantra for today's health conscious people. Cancer is a condition when the cells in the body start behaving abnormally and divide at a very fast rate.

For further information read:

http://www.medindia.com/patients
/patientinfo/superfoods_about.htm


'"/>




Page: 1

Related medicine news :

1. Tomatoes for the heart
2. Tomato Sauce reduces Cancer Risk- Study
3. A Tomato a Day Keeps Heart Disease Away
4. Tomatoes Might Inhibit the Development Of Prostate Cancer
5. Tomato: The Vaccine Plant, Against Bird Flu
6. Raspberries Are Richer In Anti-Oxidants Than Tomatoes Or Broccoli
7. Now A Cancer-Fighting Tomato
8. Reaping the Benefits of Tomato
9. Tomatoes Have Stroke and Heart Attack Prevention Properties
10. Simple remedy to prevent DVT: Eat 6 Tomatoes!
11. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
Post Your Comments:
(Date:7/9/2008)...etic outcome after lumpectomy linked to depression...9 (HealthDay News) -- A third of women who opt for...e an asymmetry between their breasts that greatly ..., Women whose affected breast looked noticeably ...ar their cancer returning and to have symptoms of ...
(Date:7/9/2008)...ship Integrates In-Store and Online Marketing to C...erience, PITTSBURGH and NEW YORK, July 9 /PRNewsw..."GNC"), the largest global specialty retailer of,n...he leading source of,health information, today ann...ase consumer awareness and understanding of the im...
(Date:7/9/2008)...LAS and PLANO, Texas, July 9 /PRNewswire/ -- SKINT... is pleased to announce the arrival,of newly FDA-a...gen filler,in the Skintastic arsenal of little-or-...s immediate, predictable visible results, with lit...orted with EVOLENCE(R) in a,comparison study again...
(Date:7/9/2008)... DRE, Inc., a premier international...its customers that as much as $250,000 in medical ...me tax filings. , Louisvi...lus Act of 2008, in accordance with Tax Code Secti... equipment bought in 2008. This could make 2008 an...
Breaking Medicine News(10 mins):Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:New Injectable Collagen Filler Offers Natural Results 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...l study found that the use of Herceptin in advance... of cardiac toxicity − nearly 28 percent of ...ical trial has yet reported;The silver lining is t...be remedied with treatment. The study, published...
...open-heart surgery was performed on a 17 yr old bo...spital// (TMCH). An eight-member team led by card...ery on the boy who was suffering from an arterial ...n the 4th of August. Dr S Balakrishnan the dean ...
...undergo surgery following an early pregnancy failu...under general anesthesia//. However a new study ha... approach. Early pregnancy failure - or EPF - occ...ognized pregnancies. Cases treated with surgery ty...
...ularity of unpasteurized milk has raised questions...ple consume unpasteurized milk for a variety of re...asteurized milk are healthier and tastier, it can’...me it do fall sick. There been have instances whe...
Other Medicine News:Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 2Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 3Health News:Women Prefer Office Procedure during treatment of Early Pregnancy 2Health News:Women Prefer Office Procedure during treatment of Early Pregnancy 3
(Date:7/7/2008)...Newswire-FirstCall/ -- Pulmo BioTech Inc. (OTC,Bul...diary, PulmoScience,Inc. has completed the bio-dis...for the PulmoBind technology of Molecular Imaging ...maging uses a molecule designed to bond specifical...lmoBind, the chosen molecule,was designed to bond ...
(Date:7/7/2008)...ewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulle...d biopharmaceutical,company specializing in the pr...ay provided an operational update on the company,s...man clinical trial testing and,plans to proceed in... Five,successful human trials evaluating GeoVax AI...
(Date:7/7/2008)...July 7 /- The Leukemia & Lymphoma,Soc...dberg M.D., M.M.Sc.,of the James P. Wilmot Cancer...ter. Millennium Pharmaceuticals, The Takeda Oncolo...rst two years of the five-year program., The Scho...will support,Dr. Friedberg,s work on a new targete...
(Date:7/6/2008)...TI,s Marketing Authorization Application currently... SEATTLE, July 7 /- Cell Th... announced the publication of results from its,ran...itaxel poliglumex,CT-2103) with gemcitabine or vi...tatus 2) patients with previously untreated non-sm...
Breaking Medicine Technology:Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5A search for protection against chemotherapy cardiotoxicity 1693 1A search for protection against chemotherapy cardiotoxicity 1693 2Certain diseases birth defects may be linked to failure of protein recycling system 1691 1Certain diseases birth defects may be linked to failure of protein recycling system 1691 2Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 1Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 1ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 3
...007 - Medtronic, Inc.,(NYSE:MDT) today announced ...l Trial indicates that the trial has met its prima...nical Trial is a randomized, single-blind,trial ev...M) Drug,Eluting Coronary Stent as compared to the ...m Boston Scientific Corporation,(NYSE:BSX). ENDEAV...
...rget from Lexicon,s Genetic,Research -, THE WOODLA...-,Lexicon Pharmaceuticals, Inc. today reported res...antibodies directed to a,potential new target, ang...triglycerides and cholesterol. Research suggests t...may have therapeutic,application in the treatment ...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: